Endoscopic sleeve gastroplasty, ESG
ESG, short for Endoscopic Sleeve Gastroplasty, is a non-surgical weight loss procedure that reduces stomach volume by 70%, promoting feelings of fullness and decreasing appetite. It involves inserting an endoscope into the stomach to place sutures along its inner lining, creating a sleeve-like shape. After the procedure, most patients could resume normal activities in 1-3 days. On average, patients lose 18% of body weight with ESG, maintaining 16% weight loss over five years.
ESG is a promising option for weight loss, boasting minimal risk and the ability to be reversed or repeated. Combined with lifestyle changes, it offers significant benefits for metabolic health and reduces the risk of obesity-related diseases like Type 2 diabetes. Additionally, temporary use of GLP-1 medication post-ESG can further enhance weight loss results up to 25%.
Advantages
- This endoscopic procedure does not create skin wounds nor resect organs.
- After the procedure, most patients could resume normal activities in 1-3 days.
- Post-procedural gastroesophageal reflux or trace element deficiency problems are rare.
Disadvantages
-
If the patient's living and eating habits have not improved, the weight loss effect of the procedure will be affected.
- Besides, it’s challenging to detect early gastric cancer lesions through endoscopy in the folded area of the stomach after the procedure.